Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Adrian Newland"'
Autor:
A. J. Gerard Jansen, Vickie McDonald, Adrian Newland, Mervyn Morgan, Mieke Bastiaanse, Koo Wilson, Daniel Eriksson, Emma Geldman, Owen Daykin-Pont, Samantha Prince, Jaap Jan Zwaginga
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjective: Identify patient experience and preference towards thrombopoietin-receptor agonists (TPO-RAs) in treatment of immune thrombocytopenia (ITP) in the Netherlands.Methods: The Thrombopoietin-Receptor Agonist Patient experience (TRAPeze
Externí odkaz:
https://doaj.org/article/cfe21626ace94a01a52f7fe1eee7fca0
Autor:
Alessandro Lucchesi, Barbara Lovrencic, Vickie McDonald, Adrian Newland, Mervyn Morgan, Daniel Eriksson, Koo Wilson, Giulio Giordano, Giuseppe Carli, Emma Geldman, Owen Daykin-Pont, Samantha Prince, Mariasanta Napolitano
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjective Identify patient preference towards thrombopoietin-receptor agonists (TPO-RAs) and determine the clinical and social impact of immune thrombocytopenia (ITP) in Italy.Methods The Thrombopoietin-Receptor Agonist Patient experience (TR
Externí odkaz:
https://doaj.org/article/b5225f288d99480c8acec0a6f831fdb8
Autor:
Monica Carpenedo, Catherine M Broome, Vickie Mcdonald, Yoshitaka Miyakawa, David Kuter, Hanny Al-Samkari, James Bussel, Filip Matthijssens, Anna Hultberg, Jaume Ayguasanosa Dachs, Kristof De Beuf, Francesco Rodeghiero, Marc Michel, Adrian Newland
Publikováno v:
HemaSphere, Vol 7, p e02996d3 (2023)
Externí odkaz:
https://doaj.org/article/ec588614d5f4449cb0dc895160e3537b
Publikováno v:
Medicina, Vol 59, Iss 4, p 815 (2023)
Primary immune thrombocytopenia (ITP) is an acquired blood disorder that causes a reduction in circulating platelets with the potential for bleeding. The incidence of ITP is slightly higher in adults and affects more women than men until 60 years, wh
Externí odkaz:
https://doaj.org/article/80fcd2d74bfa4693a233f220f8f8e1e6
Publikováno v:
PLoS Medicine, Vol 3, Iss 8 (2006)
Externí odkaz:
https://doaj.org/article/3ed28f36a480468d84b214cd62341cc3
Autor:
Kelly Gwathmey, Catherine Broome, Matthias Goebeler, Hiroyuki Murai, Zsuzsanna Bata-Csorgo, Adrian Newland, Peter Ulrichts, Rene Kerstens, Jeffrey Guptill, Sofiane Agha, Ming Jiang, James Howard
Publikováno v:
Sunday, April 23.
Autor:
Indraraj Umesh, Doobaree, Katherine, Conway, Haroon, Miah, Atiqa, Miah, Michael, Makris, Quentin, Hill, Nicola, Cooper, Charlotte, Bradbury, Adrian, Newland, Drew, Provan, Vickie, McDonald
Publikováno v:
Doobaree, I U, Conway, K, Mr, H M, Miah, A, Makris, M, Hill, Q A, Cooper, N & Bradbury, C A & Newland, A C 2022, ' Incidence of adult primary immune thrombocytopenia in England—An update ', European Journal of Haematology, vol. 109, no. 3, pp. 238-249 . https://doi.org/10.1111/ejh.13803
BackgroundAdult primary immune thrombocytopenia (ITP) is a rare bleeding disorder of unknown cause. Recent estimates of its incidence and trend over time were acquired for England.MethodThe primary ITP population (using ICD 10 code D693 and excluding
A systematic literature review on the use of platelet transfusions in patients with thrombocytopenia
Autor:
Markus Peck-Radosavljevic, Roy Bentley, Howard A. Liebman, Akiyoshi Takami, Joanna Lorens, Anna Jakubowska, Zobair M. Younossi, Ryosuke Tateishi, Adrian Newland, Vanessa Taieb
Publikováno v:
Hematology. 24:679-719
Objective: Investigate globally, current treatment patterns, benefit-risk assessments, humanistic, societal and economic burden of platelet transfusion (PT). Methods: Publications from 1998 to June 27, 2018 were identified, based on databases searche
Autor:
David J, Kuter, Adrian, Newland, Beng H, Chong, Francesco, Rodeghiero, Monica T, Romero, Ingrid, Pabinger, Yuqi, Chen, Kejia, Wang, Bhakti, Mehta, Melissa, Eisen
Publikováno v:
British Journal of Haematology
Summary The thrombopoietin receptor agonist romiplostim is approved for second‐line use in chronic immune thrombocytopenia (ITP), but its effects in patients with ITP for ≤1 year are not well characterized. This analysis of pooled data from 9 stu
Publikováno v:
Health Policy and Technology. 1:5-7
The Diagnostics Assessment Programme (DAP) was set up by NICE in 2009 to evaluate innovative medical diagnostic technologies. It was established together with the Medical Technologies Evaluation Programme (MTEP) to undertake more evaluations of medic